When insiders purchase or sell shares, it indicates their confidence or concern around the company’s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga’s insider transactions platform.
What’s Happening: InspireMD, earlier during the month, recorded a robust increase in second-quarter FY21 sales of $1.04 million, 231.6% Y/Y.
What InspireMD Does: InspireMD Inc is the United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease.
What’s Happening: The company, earlier during the month, announced licensing of BET inhibitor platform for immunoinflammatory conditions with In4Derm.
What VYNE Therapeutics Does: VYNE Therapeutics is a biopharmaceutical company which focuses on the development and commercialization of variety of solutions using its proprietary Molecule Stabilizing Technology.
What’s Happening: Vitality Biopharma, last week, entered into a definitive agreement with an institutional investor for a $5,000,000 equity line financing.
What Vitality Biopharma Does: Vitality Biopharma Inc is engaged in the development of cannabinoid prodrug pharmaceuticals.
See more from Benzinga
© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.